Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01503229
Recruitment Status : Completed
First Posted : January 2, 2012
Last Update Posted : January 19, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 12, 2017
  Study Completion Date : September 12, 2017